Company / EPS (Diluted)
Emergent BioSolutions Inc. EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$0.93
FY2025
5-year range
-$14.85 / $5.67
FY2021-FY2025
Trend
+125.8%
vs FY2024
Sector context
#33 of 204
Health Care
What the data says
Emergent BioSolutions Inc.'s eps (diluted) of $0.93 is higher than 84% of companies in the Health Care sector (FY2025). EPS (Diluted) has fluctuated over the past 10 years, ranging from $-14.85 in FY2023 to $5.67 in FY2022.
Based on SEC 10-K filings.
0.93 in FY2025 with a 5-year CAGR of -5.3%. Top quartile in the Health Care sector.
Improved from $-14.85 to $0.93 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -45.3%
- 5-Year CAGR
- -5.3%
- 10-Year CAGR
- -
Sector benchmark
+204.9% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 125.8% year-over-year.
- Ranks #33 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2022.
- Lowest eps (diluted) in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.93 | +125.8% |
| FY2024 | -$3.60 | +75.8% |
| FY2023 | -$14.85 | -361.9% |
| FY2022 | $5.67 | +39.7% |
| FY2021 | $4.06 | +232.8% |
| FY2020 | $1.22 | +17.3% |
| FY2019 | $1.04 | -8.0% |
| FY2018 | $1.13 | -19.9% |
| FY2017 | $1.41 | +60.2% |
| FY2016 | $0.88 | +3.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026